AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Datavault AI Licenses Patents for Smart Contracts in Prescription Drug Distribution Industry
ByAinvest
Wednesday, Nov 26, 2025 11:41 pm ET1min read
Datavault AI has licensed patents covering digital ledger-enabled smart contracts for commercial prescription drug distribution to Wellgistics. This exclusive arrangement positions Wellgistics as the leader in Web 3.0 Health Information Data Transfer in the $634 billion prescription drug industry. Wellgistics' proprietary EinsteinRx AI hub will facilitate automated prescription fulfillment optimization for manufacturers, pharmacies, physicians, patients, and payers. Datavault's enabling IP provides a barrier to entry in the $4.9 trillion US healthcare market. Wellgistics' PharmacyChain 'Health Data Railroad' is a revolutionary, Web 3.0 integrated smart contracts distribution infrastructure. PwC estimates a $1 trillion opportunity to shift healthcare spending towards a digital model.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet